Issue Date | Title | Author(s) |
2018-11-01 | Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities | Eapen, MS; Hansbro, PM; Larsson‑Callerfelt, AK; Jolly, MK; Myers, S; Sharma, P; Jones, B; Rahman, MA; Markos, J; Chia, C; Larby, J; Haug, G; Hardikar, A; Weber, HC; Mabeza, G; Cavalheri, V; Khor, YH; McDonald, CF; Sohal, SS |
2019-01-01 | The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases | Eapen, MS; Gaikwad, AV; Thompson, IE; Lu, W; Myers, S; Sharma, P; Sohal, SS |
2019-01-01 | Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in copd: Implications for disease progression and new therapeutics | Eapen, MS; Sharma, P; Gaikwad, AV; Lu, W; Myers, S; Hansbro, PM; Sohal, SS |
2019-02-01 | Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies | Eapen, MS; Sharma, P; Thompson, IE; Lu, W; Myers, S; Hansbro, PM; Sohal, SS |
2019-11-01 | microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer | Eapen, MS; McAlinden, KD; Myers, S; Lu, W; Sohal, SS |
2019-07-31 | New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathways | Atto, B; Eapen, MS; Sharma, P; Frey, U; Ammit, AJ; Markos, J; Chia, C; Larby, J; Haug, G; Weber, HC; Mabeza, G; Tristram, S; Myers, S; Geraghty, DP; Flanagan, KL; Hansbro, PM; Sohal, SS |
2018-10-03 | sE-cadherin and sVE-cadherin indicate active epithelial/endothelial to mesenchymal transition (EMT and EndoMT) in smokers and COPD: implications for new biomarkers and therapeutics | Eapen, MS; Myers, S; Lu, W; Tanghe, C; Sharma, P; Sohal, SS |